As a life sciences or medical device company, it is mission critical to protect lab books, drug and clinical test data, product formulas and production processes that underlie your patents, trade secrets and know-how from...more
4/4/2017
/ Biotechnology ,
Confidential Information ,
Corporate Officers ,
Cybersecurity ,
Data Breach Plans ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Incident Response Plans ,
Intellectual Property Protection ,
Life Sciences ,
Medical Devices ,
Non-Disclosure Agreement ,
Pharmaceutical Industry ,
Policies and Procedures ,
Popular ,
Trade Secrets
Cybersecurity is an issue that should be top-of-mind for all companies. But there are three misconceptions about cybersecurity that can put companies at significant risk. In this video, Foley Partner Michael Overly discusses...more
Major cybersecurity attacks of increased sophistication — and calculated to maximize the reputational and financial damage caused to the corporate targets — are now commonplace. These attacks have catapulted cybersecurity to...more